In this paper, the authors document the complex issues facing the FDA in assessing the quality of generic drugs. They conclude that increased transparency as well as the updating of FDA bioequivalence standards may be important to overcome some of these challenges.

Evidence from numerous studies shows that emerging markets have far more poor quality drugs than western markets. There are many reasons for this, but one reason, investigated in this paper, is the possibility that smaller, often privately-owned, pharmacies take greater risks with drug...

The establishment of new accounting rules for expensing options would likely do more harm than good.

This study's estimates of the reduction in accidents from a ban on cell phone use while driving are both lower and less certain than previous studies indicate.

Requiring companies to expense options in the absence of any satisfactory method to evaluate their costs would be inconsistent with the principles and objectives of accounting.

Requiring companies to expense options in the absence of any satisfactory method to evaluate their costs would be inconsistent with the principles and objectives of accounting.

The establishment of new accounting rules for expensing options would likely do more harm than good.

This volume shows that the public policy concerns are not accidental, because such industries often embody two major and widely recognized forms of potential market failure.